The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

An ETF-only portfolio is a great way to get the diversification you need.

They start thinking, ‘Well, actually, it’s not that terrible.’” This “what-if” technique, which Stewart practices on herself ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The race to IPO is on: Anthropic just filed its confidential S-1 draft. On Monday morning, the AI juggernaut announced it had turned in its first IPO proposal to the U.S. Securities and Exchange ...

It’s the deepest look yet that investors and competitors have had at the profits and losses of the company, which has grown far beyond its rocket-ship roots to include AI, an internet service provider ...

Once weekly semaglutide injections reduced alcohol consumption in patients with alcohol use disorder (AUD) and comorbid obesity. Results of the randomized controlled trial (RCT), the first, to the ...

It may sound hard to believe, but the almost trillion-dollar U.S. military is struggling to fight cheap drones in its war with Iran. Iran has also hit U.S. military bases with these drones, including ...

The National Security Agency is said to be using Mythos Preview, Anthropic’s recently announced model that it withheld from public release, Axios reports. The news comes weeks after the NSA’s parent ...

The venerable Voyager 1 spacecraft is one step closer to the end of its scientific road. NASA turned off one of its three remaining operational instruments last Friday to save power after the ...

April 19 (Reuters) - The United States National Security Agency is using Anthropic's Mythos Preview AI tool despite ‌the Pentagon hitting the company with a formal supply-chain risk designation, Axios ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...